Home  /  Resource Library  /  Overall Survival, Adverse Events, and Economic Burden in Medicare Patients with Chronic Lymphocytic Leukemia Receiving Cancer-Directed Therapy

Overall Survival, Adverse Events, and Economic Burden in Medicare Patients with Chronic Lymphocytic Leukemia Receiving Cancer-Directed Therapy

ASH 2019: Observational study examined survival, side effects and financial burden of CLL in Medicare patients in the United States.